New prostate cancer treatment improves quality of life
DutchNews.nl • • health
Key Points:
- An experimental treatment using radiation-targeted molecules has been shown to slow the spread of metastatic prostate cancer, delaying the need for hormone therapy by at least 25 months.
- The treatment involves injecting a molecule with a radioactive particle that specifically targets prostate cancer cells, minimizing damage to healthy tissue and causing no significant long-term side effects.
- Traditional hormone therapy, which is typically used when prostate cancer spreads, can cause side effects such as brittle bones, fatigue, and heart problems, which this new treatment helps to avoid or postpone.
- In the study, a quarter of patients receiving the treatment showed no tumors on subsequent scans, while those not treated experienced cancer progression within five months.
- The treatment is not yet widely available, as further research with larger patient groups is needed, and discussions with insurance companies on financing are pending.
